NCT05514769Recruiting
Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
Source: ClinicalTrials.gov · Last updated 31 Mar 2026
Brief summary (registry, in English)
This research is designed to compare proximal gastrectomy anterior anastomosis with pyloroplasty with esophagogastric anastomosis for gastric cancer. Gastroesophageal reflux disease, postoperative quality of life, short term outcomes, and long term outcomes will be compared.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 21 Aug 2022
- Start date
- 1 Jan 2021
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Nanchong Central Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05514769
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jan 2021 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous chemotherapy or radiation therapy for any other malignancies.
Other
- Patients had distant metastasis.
- oesophageal invasion of more than 3 cm.
- Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
Who the study is looking for
- Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
- Eastern Cooperative Oncology Group performance status of 0 or 1.
- Adequate organ function.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yunhong Tian Coordinator of this site? Confirm its status | Nanchong | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.